MedTrace Logo

Duration of Antibiotic Therapy in Community - Acquired Pneumonia

NCT01492387 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 892

Last updated 2014-01-03

No results posted yet for this study

Summary

The purpose of the study is to assess the efficacy of an individualized approach to duration of antibiotic therapy based on each subject's clinical response compared to a local standard approach in patients coming from the community and who are hospitalized because of a pneumonia.

Conditions

  • Pneumonia
  • Bronchopneumonia
  • Pleuropneumonia
  • Pneumonia, Bacterial
  • Pneumonia, Viral

Interventions

OTHER

Discontinuation of antibiotic therapy

Patients randomized in the Individualized Arm will be treated according to clinical response: antibiotic therapy will be discontinued 48 hours after the day that the patient reaches clinical stability, with at least 5 days of total antibiotic treatment.

Sponsors & Collaborators

  • University of Milano Bicocca

    collaborator OTHER

  • University of Milan

    lead OTHER

Principal Investigators

  • Stefano Aliberti, MD · University of Milano Bicocca, Milan, Italy

  • Julio A Ramirez, MD · University of Louisville, KY, USA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-12-31
Completion
2015-03-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01492387 on ClinicalTrials.gov